An overview of human infections / Review Article

Article Sidebar

pdf
Published: Feb 16, 2024
Keywords:
Human Infections Pathogenic Virus and Bacteria

Main Article Content

Suhad Y Abed
Department of Biology Science, Mustansiriyah University, POX 46079, Iraq-Baghdad.
Shahla Hussien Huno
Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq,Baghdad
Enaam Hameed Batah
Department of Biology Science, Mustansiriyah University, POX 46079, Iraq-Baghdad
Abdalkader Saeed Latif
National University of Science and Technology / College of Health and Medical Technology

Abstract

Microbes of all kinds spread around us, whether they are viruses or bacteria, and perhaps some may wonder about the difference between a virus and bacteria, especially after the spread of the Corona virus pandemic, which caused some concepts to be confused and to treat the virus as if it were a bacterial infection, which called on doctors to try to correct misconceptions, explaining the difference between viruses and bacteria, methods of treating both viruses and bacteria are transmitted to humans

Article Details

How to Cite
Suhad Y Abed, Shahla Hussien Huno, Enaam Hameed Batah, & Abdalkader Saeed Latif. (2024). An overview of human infections / Review Article. The Peerian Journal, 27, 144–153. Retrieved from https://peerianjournal.com/index.php/tpj/article/view/766
Issue
Vol. 27 (2024): TPJ
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Hu J, . The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Adv Virol. 2021;166:2649–72.

-Yasamineh S, . Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19. Stem Cell Res Ther. 2022;13(1):257.

-Oveili E, . The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases. Cell Commun Signal. 2023;21(1):1–26.

-Saadh MJ, . Progress and prospects on vaccine development against Monkeypox Infection. Microb Pathog. 2023;180:106156.

-Gholizadeh O, et al. Recent advances in treatment Crimean-Congo hemorrhagic fever virus: a concise overview. Microb Pathog. 2022;169:105657.

-Žigrayová D, Mikušová V, Mikuš P. Advances in antiviral delivery systems and chitosan-based polymeric and nanoparticulate antivirals and antiviral carriers. Viruses. 2023;15(3):647.

-Gholizadeh O, . Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview. Virol J. 2022;19(1):206.

-Gholizadeh O, . The role of non-coding RNAs in the diagnosis of different stages (HCC, CHB, OBI) of hepatitis B infection. Microb Pathog. 2023;176:105995.

-Nasiri K, . Spotlight on the impact of viral infections on Hematopoietic Stem Cells (HSCs) with a focus on COVID-19 effects. Cell Commun Signal. 2023;21(1):1–15.

-Pradhan D, l. Recent advancement in nanotechnology-based drug delivery system against viral infections. AAPS PharmSciTech. 2021;22:1–19.

-Mallipeddi R, Rohan LC. Nanoparticle-based vaginal drug delivery systems for HIV prevention. Expert Opin Drug Deliv. 2010;7(1):37–48.

-Norouzi M, N. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection. Mater Sci Eng C. 2019;104:110007.

-Yasamineh S, l. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19. J Nanobiotechnol. 2022;20(1):1–26.

-Yasamineh S, et al. A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. Int J Pharm. 2022;624:121878.

-Assefi M, G. A state-of-the-art review on solid lipid nanoparticles as a nanovaccines delivery system. J Drug Deliv Sci Technol. 2023;104623.

-Zhou Y, Han Y. Engineered bacteria as drug delivery vehicles: principles and prospects. Eng Microbiol. 2022;2:100034.

-Yasamineh S, L. Future prospects of natural polymer-based drug delivery systems in combating lung diseases. In: Natural polymeric materials based drug delivery systems in lung diseases. New York: Springer; 2023. p. 465–82.

-Xie S, O. Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release. J Control Release. 2017;268:390–9.

-Wu D, U. Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression. Acta Biomater. 2023.

-Chen H, Advances in Escherichia coli Nissle, . As a customizable drug delivery system for disease treatment and diagnosis strategies. Mater Today Bio. 1917;2023:100543.

-Chen W, F. Advances in Salmonella typhimurium-based drug delivery system for cancer therapy. Adv Drug Deliv Rev. 2022;185:114295.

-Moghimipour E, D. Bacteria and archaea: a new era of cancer therapy. J Control Release. 2021;338:1–7.

-Xie S, S. Bacterial navigation for tumor targeting and photothermally-triggered bacterial ghost transformation for spatiotemporal drug release. Acta Biomater. 2021;131:172–84.

-Zhao G, Jones MK. Role of bacterial extracellular vesicles in manipulating infection. Infect Immun. 2023;91(5):e00439-e522

-Zhu Z, M. Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance. MBio. 2021;12(4):10–1128.